335650-15-2 Usage
Class
Pyrrolidinecarboxylic acids
Explanation
1-Pyrrolidinecarboxylic acid, 2-(hydroxymethyl)-4-methoxy-, phenylmethyl ester (2S,4R)belongs to a class of chemical compounds called pyrrolidinecarboxylic acids.
Explanation
The compound has a molecular formula of C15H21NO4, indicating the number of carbon (C), hydrogen (H), nitrogen (N), and oxygen (O) atoms in the molecule.
3. Phenylmethyl ester
Explanation
The compound is a phenylmethyl ester, which means it has a phenyl group (a ring structure with a methyl side chain) attached to the carboxyl group of the pyrrolidinecarboxylic acid.
Explanation
The (2S,4R)designation indicates the specific spatial arrangement of atoms in the molecule, which can significantly affect its biological activity.
5. Biological and medicinal properties
Explanation
1-Pyrrolidinecarboxylic acid, 2-(hydroxymethyl)-4-methoxy-, phenylmethyl ester (2S,4R)is known for its potential biological and medicinal properties, making it a subject of interest in pharmaceutical and research applications.
6. Drug development and medicinal chemistry
Explanation
Ongoing research is being conducted on this compound to explore its potential uses in drug development and medicinal chemistry, due to its unique structure and properties.
Stereochemistry
(2S,4R)-
Check Digit Verification of cas no
The CAS Registry Mumber 335650-15-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,3,5,6,5 and 0 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 335650-15:
(8*3)+(7*3)+(6*5)+(5*6)+(4*5)+(3*0)+(2*1)+(1*5)=132
132 % 10 = 2
So 335650-15-2 is a valid CAS Registry Number.
335650-15-2Relevant articles and documents
ANTI-INFLAMMATORY COMPOUND HAVING INHIBITORY ACTIVITY AGAINST MULTIPLE TYROSINE KINASES AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
-
Paragraph 0706; 0709; 0710, (2013/03/28)
The present invention is for the anti-inflammatory compounds that have an inhibitory activity against protein tyrosine kinases and their pharmaceutical composition(s) containing the compound as the active ingredient. Since the compounds of the present invention can inhibit multiple protein kinases associated with inflammatory diseases and immune disorders, they are useful for their prevention or treatment.
BICYCLIC UNSATURATED TERTIARY AMINE COMPOUND
-
Page/Page column 79, (2010/02/11)
The present invention provides a bicyclic unsaturated tertiary amine compound capable of inhibiting the production of inflammatory cytokines.A compound of the following formula (1): (wherein, A represents pyrrole or pyrazole, R1 represents an aryl group or a heteroaryl group which may be substituted, R2 represents a heteroaryl group which may be substituted, and R3 represents an indolizine group), or a pharmacologically acceptable salt thereof, a pharmacologically acceptable ester thereof or other pharmacologically acceptable derivative thereof.
Tyrosine kinase inhibitors
-
, (2008/06/13)
The present invention relates to compounds which inhibit, regulate and/or modulate tyrosine kinase signal transduction, compositions which contain these compounds, and methods of using them to treat tyrosine kinase-dependent diseases and conditions, such as angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases, and the like in mammals.
